MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy. (Q36552798)
Jump to navigation
Jump to search
scientific article published on 17 December 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy. |
scientific article published on 17 December 2012 |
Statements
MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy (English)
Beatriz González
Raul Ortiz
Angel Concha
Jaime Antonio Oliver
Rodrigo López
Antonia Aránega
17 December 2012